Immunology and Biotherapies
44.8K views | +0 today
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
July 31, 2012 4:16 AM
Scoop.it!

World's first dengue vaccine beats three virus strains - Fox News

World's first dengue vaccine beats three virus strains - Fox News | Immunology and Biotherapies | Scoop.it
World's first dengue vaccine beats three virus strainsFox NewsSanofi's vaccine generated an antibody response for all four dengue virus types, but evidence of protection was only demonstrated against three of the four strains circulating in Thailand.
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 2:34 PM
Scoop.it!

Rheumatologe: The Anti-IL17A Monoclonal Antibody Secukinumab in the Treatment of Active Ankylosing Spondylitis

Rheumatologe: The Anti-IL17A Monoclonal Antibody Secukinumab in the Treatment of Active Ankylosing Spondylitis | Immunology and Biotherapies | Scoop.it
The Anti-IL17A Monoclonal Antibody Secukinumab in ...
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 1:28 PM
Scoop.it!

Published Findings In Human Gene Therapy Methods Journal Demonstrate ... - MarketWatch (press release)

Published Findings In Human Gene Therapy Methods Journal Demonstrate ... - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it
Published Findings In Human Gene Therapy Methods Journal Demonstrate ...MarketWatch (press release)"The clinical success of DNA-based therapies can be enhanced by employing optimized gene delivery methods," stated Dr.
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 1:24 PM
Scoop.it!

New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab ... - MarketWatch (press release)

New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab ... - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it
New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab ...MarketWatch (press release)Lpath utilized ImmuneY2 to discover an antibody against another bioactive lipid, sphingosine-1-phosphate (S1P).
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 4:01 PM
Scoop.it!

CIRM awards $151 million in stem cell grants to 8 projects statewide - 89.3 KPCC

CIRM awards $151 million in stem cell grants to 8 projects statewide - 89.3 KPCC | Immunology and Biotherapies | Scoop.it
89.3 KPCCCIRM awards $151 million in stem cell grants to 8 projects statewide89.3 KPCCThis week, California's public stem-cell agency awarded more than $150 million to advance research into eight diseases now under study by researchers at several...
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 3:35 AM
Scoop.it!

Lame dogs brought to heal with stem cells - World News - World - General - Great Lakes Advocate

Lame dogs brought to heal with stem cells - World News - World - General - Great Lakes Advocate | Immunology and Biotherapies | Scoop.it
Stem cell injections in dogs will become routine in the next two years and will probably cost less than $1000.
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 3:14 AM
Scoop.it!

Should high-dose interleukin-2 continue to be the treatment of ...

Should high-dose interleukin-2 continue to be the treatment of ... | Immunology and Biotherapies | Scoop.it
Cancer Biotherapy and Radiopharmaceuticals (http://www.liebertpub.com/cbr), published 10 times a year in print and online, is under the editorial leadership of Editors Donald J. Buchsbaum, PhD and Robert K.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 3:07 PM
Scoop.it!

Anti-tumor Properties of Particular Monoclonal Antibodies Specific for

Anti-tumor Properties of Particular Monoclonal Antibodies Specific for | Immunology and Biotherapies | Scoop.it
ROR1, receptor tyrosine kinase like orphan receptor one, is a molecule expressed at high levels during embryogenesis that plays a major role in the development of the skeleton, lungs and nervous sy...
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 3:02 PM
Scoop.it!

MHC-Resident Variation Affects Risks After Un... [Sci Transl Med. 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 2:58 PM
Scoop.it!

Clinical Immunology Society Announces Updated WEBbook of Biologic ... - DigitalJournal.com (press release)

Clinical Immunology Society Announces Updated WEBbook of Biologic ...DigitalJournal.com (press release)The Clinical Immunology Society (CIS) maintains the WEBbook of Biologic Therapies as a service to the Society members and the medical community...
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 5:09 AM
Scoop.it!

OMT Announces New Antibody Discovery Program - MarketWatch (press release)

OMT Announces New Antibody Discovery Program - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it
OMT Announces New Antibody Discovery ProgramMarketWatch (press release)Open Monoclonal Technology, Inc. ("OMT") is a private biotechnology company that is the first to develop a fully human monoclonal antibody platform based on transgenic rats.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 2:46 AM
Scoop.it!

SDSU researchers use stem cells to repair damaged heart tissue

SAN DIEGO (CNS) - Researchers from San Diego State University's Heart Institute rejuvenated damaged cardiac tissue removed from older heart-failure patients, using modified stem cells.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 2:43 AM
Scoop.it!

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controll...

“@Artritis_Celso:Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive,RA pat.
No comment yet.
Scooped by Gilbert C FAURE
July 31, 2012 4:12 AM
Scoop.it!

Drug from Mediterranean weed kills tumor cells in mice : Johns Hopkins University – The Gazette

Drug from Mediterranean weed kills tumor cells in mice : Johns Hopkins University – The Gazette | Immunology and Biotherapies | Scoop.it
RT @JohnsHopkins: Drug from Mediterranean weed kills tumor cells in mice http://t.co/U62anDcj...
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 1:29 PM
Scoop.it!

UniQure's Glybera Wins EU Backing as First Gene Therapy - Businessweek

UniQure's Glybera Wins EU Backing as First Gene Therapy - Businessweek | Immunology and Biotherapies | Scoop.it
BBC NewsUniQure's Glybera Wins EU Backing as First Gene TherapyBusinessweekEurope is on the cusp of approving the first gene therapy to be sold on the market in a western nation, a product from UniQure BV designed to treat a rare disease that...
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 1:27 PM
Scoop.it!

Research from University of Oxford Has Provided New Information about ... - Equities.com

Research from University of Oxford Has Provided New Information about ... - Equities.com | Immunology and Biotherapies | Scoop.it
Research from University of Oxford Has Provided New Information about ...Equities.comAccording to news reporting from Oxford, United Kingdom, by NewsRx journalists, researchers stated "Ipilimumab (Yervoy; Medarex and Bristol-Myers Squibb) is a...
No comment yet.
Scooped by Gilbert C FAURE
July 30, 2012 1:23 PM
Scoop.it!

iBio, Inc. and GE Healthcare form new global alliance - MarketWatch (press release)

iBio, Inc. and GE Healthcare form new global alliance - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it
iBio, Inc.and GE Healthcare form new global allianceMarketWatch (press release)We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global...
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 2:52 PM
Scoop.it!

Researchers Study Vaccine Created from Patient Blood Cells as Potential ... - MarketWatch (press release)

Researchers Study Vaccine Created from Patient Blood Cells as Potential ... - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it
Researchers Study Vaccine Created from Patient Blood Cells as Potential ...MarketWatch (press release)Researchers at Northwestern Brain Tumor Institute (NBTI) are seeking to understand if a vaccine made from a patient's own blood cells may slow the...
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 3:19 AM
Scoop.it!

Product Protocol: TNFSF10 antibody used to evaluate type i interferon

Product Protocol: TNFSF10 antibody used to evaluate type i interferon | Immunology and Biotherapies | Scoop.it
Specificity: CD253 Product Page: TNFSF10 antibody (OASA07564) Antibody Pair Available: OASA07564 Capture OASA07567 Detection Experiment Type: Mice and treatments, Antibodies, flow cytometry, and cell sorting ...
No comment yet.
Scooped by Gilbert C FAURE
July 29, 2012 3:14 AM
Scoop.it!

PipelineReview.com - Biotech News & Online Store - Companies to ...

PipelineReview.com - Biotech News & Online Store - Companies to ... | Immunology and Biotherapies | Scoop.it
We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global effort to increase access to biotherapeutics and help reduce the ...
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 3:06 PM
Scoop.it!

Shanghai Pasteur developed for the intestinal virus EV71 neutralizing

Shanghai Pasteur developed for the intestinal virus EV71 neutralizing | Immunology and Biotherapies | Scoop.it
More importantly, in vitro experiments, the monoclonal antibody in very low concentrations can effectively prevent the virus from invading cells, suggesting that they have developed into a humanized monoclonal antibody drug ...
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 3:01 PM
Scoop.it!

Symposier - Immunosuppression in Transplantation

Symposier - Immunosuppression in Transplantation | Immunology and Biotherapies | Scoop.it
Uploaded and Shares in Youtube by: AssoEFP

Mechanism of action of dual-immunosuppression in solid organ transplantation.

EFP website: www.efp-online.org.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 2:52 PM
Scoop.it!

Vitamin D deficiency, CD4+CD28null cell... [Nephrology (Carlton). 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 4:21 AM
Scoop.it!

Nanoscale scaffolds spur stem cells to cartilage repair

Nanoscale scaffolds spur stem cells to cartilage repair | Immunology and Biotherapies | Scoop.it
Posted: Jul 26th, 2012. Nanoscale scaffolds spur stem cells to cartilage repair. (Nanowerk News) A spun 3-D scaffold of nanofibers did a better job of producing larger quantities of and a more durable type of the cartilage protein than flat, 2-D ...
No comment yet.
Scooped by Gilbert C FAURE
July 28, 2012 2:43 AM
Scoop.it!

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study : The Lancet

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. By - Prof Martin J Elliott MD, Paolo De Coppi MD, Simone Speggiorin MD, Derek Roebuck MB, Colin R Butle...
No comment yet.